FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2997234210> ?p ?o ?g. }

• W2997234210 endingPage "109712" @default.
• W2997234210 startingPage "109712" @default.
• W2997234210 abstract "Human multiple myeloma (MM) is a malignant and incurable B cell tumor. Zinc oxide nanoparticles (ZnO NPs) have been widely used in biomedical fields including anti-bacterial and anti-tumor. However, the influence of ZnO NPs on MM cells is still unclear. The present study aimed to investigate the effect of ZnO NPs on MM cell (a human myeloma-derived RPMI8226 cell line) death in vitro and the underlying mechanism. The morphology of ZnO NPs was characterized by transmission electron microscopy (TEM), and the inhibitory and apoptotic effect of ZnO NPs on human MM cells was monitored by a CCK-8 method and an Annexin V-FITC/PI assay. Meanwhile, the morphological change in the cells after exposure to ZnO NPs was observed by a light field microscope. Moreover, the effects of ZnO NPs on the ATP level, reactive oxygen species (ROS) generation, and apoptosis were separately explored by the DCFH-DA fluorescent probe, flow cytometry, and ATP bioluminescence assay. Moreover, the expression of cytochrome C (Cyt-C), Apaf-1, Caspase-9 and Caspase-3 at mRNA and protein levels was further determined by using quantitative PCR (Q-PCR) and western blotting. In the present study, the human peripheral blood mononuclear cells (PBMCs) were used as normal control samples for the relevant experiment. The results indicated that ZnO NPs could significantly inhibit human MM cell proliferation and cell death in a time- and dose-dependent manner in vitro, and this outcome can be confirmed by cell morphology and apoptosis assay. Meanwhile, the results also showed that ZnO NPs could effectively increase ROS production and decrease ATP levels in human MM cells. ZnO NPs could also significantly elevate the expression of Cyt-C, Apaf-1, Caspase-9 and Caspase-3 at mRNA and protein levels, leading to cell death. By contrast, ZnO NPs showed little cytotoxic influence on PBMCs. ZnO NPs can significantly induce human MM cell death in a time- and dose-dependent manner in vitro, decrease the ATP production and enhance the ROS generation. ZnO NPs can also increase Cyt-C, Apaf-1, Caspase-9 and Caspase-3 expression at mRNA and protein levels in human MM cells, and initiate MM cell apoptosis, indicating that Cyt-C, Apaf-1, Caspase-9 and Caspase-3 play crucial roles in ZnO NPs-induced, mitochondria-mediated apoptosis in human MM cells. Overall, ZnO NPs may be a potential agent in treating human multiple myeloma in clinical practice." @default.
• W2997234210 created "2020-01-10" @default.
• W2997234210 creator A5004793157 @default.
• W2997234210 creator A5019336865 @default.
• W2997234210 creator A5032564609 @default.
• W2997234210 creator A5033552109 @default.
• W2997234210 creator A5037826924 @default.
• W2997234210 creator A5046141625 @default.
• W2997234210 creator A5049683981 @default.
• W2997234210 creator A5077764073 @default.
• W2997234210 date "2020-02-01" @default.
• W2997234210 modified "2023-10-14" @default.
• W2997234210 title "Zinc oxide nanoparticles induce human multiple myeloma cell death via reactive oxygen species and Cyt-C/Apaf-1/Caspase-9/Caspase-3 signaling pathway in vitro" @default.
• W2997234210 cites W107503796 @default.
• W2997234210 cites W1504443599 @default.
• W2997234210 cites W1944329936 @default.
• W2997234210 cites W1966626824 @default.
• W2997234210 cites W1968953482 @default.
• W2997234210 cites W1972624235 @default.
• W2997234210 cites W1982225458 @default.
• W2997234210 cites W1984534203 @default.
• W2997234210 cites W2001961700 @default.
• W2997234210 cites W2012319331 @default.
• W2997234210 cites W2012790616 @default.
• W2997234210 cites W2013112981 @default.
• W2997234210 cites W2013183971 @default.
• W2997234210 cites W2021977009 @default.
• W2997234210 cites W2025725394 @default.
• W2997234210 cites W2040658267 @default.
• W2997234210 cites W2046660653 @default.
• W2997234210 cites W2060775307 @default.
• W2997234210 cites W2066222211 @default.
• W2997234210 cites W2070032426 @default.
• W2997234210 cites W2070124969 @default.
• W2997234210 cites W2079317778 @default.
• W2997234210 cites W2098422029 @default.
• W2997234210 cites W2099751788 @default.
• W2997234210 cites W2103289668 @default.
• W2997234210 cites W2124560610 @default.
• W2997234210 cites W2143916054 @default.
• W2997234210 cites W2146915953 @default.
• W2997234210 cites W2158685498 @default.
• W2997234210 cites W2202835482 @default.
• W2997234210 cites W2336232418 @default.
• W2997234210 cites W2521458661 @default.
• W2997234210 cites W2528855337 @default.
• W2997234210 cites W2531356984 @default.
• W2997234210 cites W2549893547 @default.
• W2997234210 cites W2551296276 @default.
• W2997234210 cites W2559759683 @default.
• W2997234210 cites W2609871459 @default.
• W2997234210 cites W2614402204 @default.
• W2997234210 cites W2616809690 @default.
• W2997234210 cites W2621134841 @default.
• W2997234210 cites W2625402676 @default.
• W2997234210 cites W2737561725 @default.
• W2997234210 cites W2748300815 @default.
• W2997234210 cites W2752844863 @default.
• W2997234210 cites W2765337989 @default.
• W2997234210 cites W2793114286 @default.
• W2997234210 cites W2803535029 @default.
• W2997234210 cites W2883301586 @default.
• W2997234210 cites W4252175385 @default.
• W2997234210 doi "https://doi.org/10.1016/j.biopha.2019.109712" @default.
• W2997234210 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31918281" @default.
• W2997234210 hasPublicationYear "2020" @default.
• W2997234210 type Work @default.
• W2997234210 sameAs 2997234210 @default.
• W2997234210 citedByCount "51" @default.
• W2997234210 countsByYear W29972342102020 @default.
• W2997234210 countsByYear W29972342102021 @default.
• W2997234210 countsByYear W29972342102022 @default.
• W2997234210 countsByYear W29972342102023 @default.
• W2997234210 crossrefType "journal-article" @default.
• W2997234210 hasAuthorship W2997234210A5004793157 @default.
• W2997234210 hasAuthorship W2997234210A5019336865 @default.
• W2997234210 hasAuthorship W2997234210A5032564609 @default.
• W2997234210 hasAuthorship W2997234210A5033552109 @default.
• W2997234210 hasAuthorship W2997234210A5037826924 @default.
• W2997234210 hasAuthorship W2997234210A5046141625 @default.
• W2997234210 hasAuthorship W2997234210A5049683981 @default.
• W2997234210 hasAuthorship W2997234210A5077764073 @default.
• W2997234210 hasBestOaLocation W29972342101 @default.
• W2997234210 hasConcept C121332964 @default.
• W2997234210 hasConcept C12519072 @default.
• W2997234210 hasConcept C137061746 @default.
• W2997234210 hasConcept C153911025 @default.
• W2997234210 hasConcept C169274487 @default.
• W2997234210 hasConcept C185592680 @default.
• W2997234210 hasConcept C190283241 @default.
• W2997234210 hasConcept C202751555 @default.
• W2997234210 hasConcept C29311851 @default.
• W2997234210 hasConcept C31573885 @default.
• W2997234210 hasConcept C48349386 @default.
• W2997234210 hasConcept C54355233 @default.
• W2997234210 hasConcept C553184892 @default.
• W2997234210 hasConcept C55493867 @default.
• W2997234210 hasConcept C62520636 @default.

• next